Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids

Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies

(2015) Walter Krause Neto et al.   AGE

The Impact of Nandrolone Decanoate on the Central Nervous System

(2015) Francesco Busardo et al.   Current Neuropharmacology

Anabolic Androgenic Steroid (AAS) Related Deaths: Autoptic, Histopathological and Toxicological Findings

(2015) Paola Frati et al.   Current Neuropharmacology

Testosterone Therapy and Cardiovascular Risk: Advances and Controversies

(2015) Abraham Morgentaler et al.   MAYO CLINIC PROCEEDINGS

Comparative Safety of Testosterone Dosage Forms

(2015) J. Bradley Layton et al.   JAMA Internal Medicine

Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

(2014) Harrison G. Pope et al.   ENDOCRINE REVIEWS

Enobosarm (GTx-024, S-22): a potential treatment for cachexia

(2014) Reshmi Srinath et al.   Future Oncology

Sudden or Unnatural Deaths Involving Anabolic-androgenic Steroids

(2014) Shane Darke et al.   JOURNAL OF FORENSIC SCIENCES

Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling

(2014) Ramesh Narayanan et al.   PLoS One

Androgen Receptor Roles in the Development of Benign Prostate Hyperplasia

(2013) Kouji Izumi et al.   AMERICAN JOURNAL OF PATHOLOGY

A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

(2013) Dimitris A. Papanicolaou et al.   Journal of Nutrition Health & Aging

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

(2013) Adrian S Dobs et al.   LANCET ONCOLOGY

Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer

(2013) James T. Dalton et al.   Current Opinion in Supportive and Palliative Care

Deciphering the selective androgen receptor modulators paradigm

(2012) Xuqing Zhang et al.   Expert Opinion on Drug Discovery

Low Testosterone Concentrations in Men Contribute to the Gender Gap in Cardiovascular Morbidity and Mortality

(2012) Robin Haring et al.   Gender Medicine

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity

(2012) Katya B. Rubinow et al.   JOURNAL OF LIPID RESEARCH

The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men

(2012) Shehzad Basaria et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Increased atherothrombotic markers and endothelial dysfunction in steroid users

(2012) Cátia B Severo et al.   European Journal of Preventive Cardiology

Differing levels of testosterone and the prostate: a physiological interplay

(2011) S. Larry Goldenberg et al.   Nature Reviews Urology

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

(2011) James T. Dalton et al.   Journal of Cachexia Sarcopenia and Muscle

Effects of Synthetic Androgens on Liver Function Using the Rabbit as a Model

(2010) S. A. Hild et al.   JOURNAL OF ANDROLOGY

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

(2010) M. Mercè Fernández-Balsells et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adverse health effects of anabolic–androgenic steroids

(2010) Jan van Amsterdam et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Chromosome damage and cytotoxicity in oral mucosa cells after 2 months of exposure to anabolic steroids (decadurabolin and winstrol) in weight lifting

(2010) Renato A. Martins et al.   STEROIDS

Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study

(2009) T. Vikan et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Testosterone and Prostate Cancer: Revisiting Old Paradigms

(2009) Hendrik Isbarn et al.   EUROPEAN UROLOGY

Improving selective androgen receptor modulator discovery and preclinical evaluation

(2009) Jeremy Orion Jones   Expert Opinion on Drug Discovery

Illicit anabolic–androgenic steroid use

(2009) Gen Kanayama et al.   HORMONES AND BEHAVIOR

Safety of testosterone use in women

(2009) Chrisandra L. Shufelt et al.   MATURITAS

Pharmacology of anabolic steroids

(2008) A T Kicman   BRITISH JOURNAL OF PHARMACOLOGY

Ischemic Stroke Related to Anabolic Abuse

(2008) Rodrigo Daniel Santamarina et al.   CLINICAL NEUROPHARMACOLOGY

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

(2008) Daniel J. Rader et al.   JOURNAL OF LIPID RESEARCH

Pharmacokinetics and Pharmacodynamics of LGD-3303 [9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an Orally Available Nonsteroidal-Selective Androgen Receptor Modulator

(2008) E. G. Vajda et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

A selective androgen receptor modulator with minimal prostate hypertrophic activity restores lean body mass in aged orchidectomized male rats

(2008) George Allan et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Low Serum Testosterone and Mortality in Older Men

(2007) Gail A. Laughlin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM